Total Visits

Views
Predictive value of interim 18F-FDG-PET/CT for event-free survival in patients with diffuse large B-cell lymphoma homogenously treated in a phase II trial with six cycles of R-CHOP-14 plus pegfilgrastim as first-line treatment54

Select a period of time:

Views

Views
November 20250
December 20252
January 20261
February 20260
March 20263
April 20261
May 20260
Download CSV file
 untranslated
 untranslated

Top country views

Views
Algeria1
Finland1
France1
United Kingdom1
Ireland1
Mexico1
United States1
 

Top cities views

Views
Blida1
Cardiff1
Helsinki1
Santa Clara1
Tralee1